PsychEd4Peds: child mental health podcast for pediatric clinicians

Elise Fallucco M.D.

PsychEd4Peds is the child mental health podcast designed for pediatric clinicians - helping you help kids. The host, Dr. Elise Fallucco, M.D., is a board-certified child and adolescent psychiatrist and mom of three who teaches pediatric clinicians to identify, manage, and support kids and teens with mental health problems.  Dr. Fallucco interviews experts in the fields of child psychiatry, psychology, and pediatrics to share practical tools, tips, and strategies to help pediatric clinicians take care of kids and teens.

read less
Health & FitnessHealth & Fitness

Episodes

33. Advanced Q+A about Meds for ADHD, Anxiety with Dr. Jeffrey Strawn
Feb 19 2024
33. Advanced Q+A about Meds for ADHD, Anxiety with Dr. Jeffrey Strawn
It's time for some Advanced Q+A with Dr. Jeffrey Strawn about medication treatment for ADHD +/- Anxiety!?Q:? When do you use alpha agonists (like Clonidine, Guanfacine)??A:  as adjunctive treatment for kids who are having trouble tolerating stimulants,  and/or who have residual impulsivity when they're being treated with stimulants.  Q: How can you prescribe alpha-agonists to kids who cannot swallow pills?A: We've talked about the possibility of using compounding pharmacies to help create liquid formulations of certain short acting alpha agonists for kids who have trouble swallowing pills. Q: When/ would you *start* treatment for ADHD with an alpha-agonist?A: Almost Never.  Start with stimulant medication when you're considering medication treatment for ADHD, regardless of how old the child is.   So for preschool aged children with ADHD for whom you're considering medication treatment, start with stimulant medication as opposed to non-stimulant medication.  Side note: Atomoxetine or Straterra is not as effective as first-line treatments for ADHD, nor is it as effective as our first-line treatments for anxiety. And finally we covered the amazing resource of Case Studies: Stahl's Essential Psychopharmacology: Volume 4: Children and Adolescents by Jeffrey R. Strawn and Stephen M. Stahl | Nov 9, 2023 available on Amazon and through Cambridge University PressCheck out our website PsychEd4Peds.com for more resources.Follow us on Instagram @psyched4peds
32. Meds for ADHD and/or anxiety
Feb 9 2024
32. Meds for ADHD and/or anxiety
Is there a go-to medication to treat a child with both ADHD and anxiety?  Join us as we continue the conversation with Dr. Jeffrey Strawn from Cincinnati Children's Medical Center to discuss how to approach medication treatment for a child with ADHD and anxiety.  We talk about which stimulants are better tolerated, when to use alpha 2 agonists (like clonidine and guanfacine), and finally what to know about the norepinephrine reuptake inhibitors, Viloxazine (Qelbree) and atomoxetine (Strattera). Key Points:1 – treat ADHD first, then address residual anxiety (unless anxiety is Severe)2 – When treating ADHD, start with stimulants;  Methylphenidate (MPH) stimulants are less likely to cause mood/anxiety sxs than mixed-amphetamine salts; MPH stimulants also have  ½ incidence of appetite suppression relative to the mixed-amphetamine salts3 – When to use alpha 2-agonistso   Clonidine is “a little messier” – hits multiple receptors (alpha 2a, 2b, 2c; hits imidazoline receptor), more likely to affect BP, sedation; best for problems initiating sleep o   Guanfacine – “much more selective for alpha 2 A receptor”,o   Guanfacine XR can be dosed once daily (vs. clonidine xr which is still BID) o   Dosing and titration of Guanfacine XR stay below 6mg, 0.1 mg/kg/dayo   Guanfacine XR considered as adjunctive med in addition to SSRI for anxietyo   Good to help w/ impulsivity4 – Viloxazine/Qelbree (NRI) “what’s hype vs. what’s clinically relevant pharmacology?”o   Works more rapidly than atomoxetine: Even within first couple of weeks, noticing improvement in symptomso   Little 2D6 metabolism, but not affected by 2D6 metabolizer status like atomoxetine (did you know fda recommends different dosing/titration based on metabolizer status in atomoxetine)o   Potent CYP 1A2 inhibitor (which metabolizes caffeine/energy drinks)  increase caffeine exposure (blood level over time) six fold ** ADR2A genetic polymorphism means 2/3 people do NOT experience anxiety when they consume caffeineDr. Jeff Strawn is a Professor of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine.  Dr. Strawn directs the Anxiety Disorders Research Program and conducts clinical trials and neuroimaging studies in patients with anxiety and related disorders.  He is an internationally recognized expert int he field of child and adolescent anxiety disorders.Check out our website PsychEd4Peds.com for more resources.Follow us on Instagram @psyched4peds